Author:
Lawitz Eric,Poordad Fred,Kowdley Kris V.,Cohen Daniel E.,Podsadecki Thomas,Siggelkow Sara,Larsen Lois,Menon Rajeev,Koev Gennadiy,Tripathi Rakesh,Pilot-Matias Tami,Bernstein Barry
Reference15 articles.
1. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases;Ghany;Hepatology,2011
2. Clinical practice. Chronic hepatitis C infection;Rosen;New Engl J Med,2011
3. Pharmacokinetics and tolerability of the HCV protease inhibitor ABT-450 following single ascending doses in healthy adult volunteers with and without ritonavir;Menon;Global Antiviral J,2009
4. Initial antiviral activity of the HCV NS3 protease inhibitor ABT-450 when given with low dose ritonavir as 3-day monotherapy: preliminary results of study M11–602 in genotype 1 (GT1) HCV infected treatment-naïve subjects;Lawitz;Hepatology,2010
5. Genotypic and phenotypic characterization of NS3 variants selected in HCV-infected patients treated with ABT-450;Pilot-Matias;J Hepatol,2011
Cited by
60 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献